Homozygous missense variants in BMPR15 can result in primary ovarian insufficiency.

Reprod Biomed Online

Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester Manchester, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust Manchester, UK. Electronic address:

Published: October 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Research Question: Does a genetic condition underlie the diagnosis of primary ovarian insufficiency (POI) in a 13-year-old girl with primary amenorrhoea?

Design: A case report of a next-generation sequencing panel of 24 genes associated with syndromal and non-syndromal POI was conducted.

Results: A homozygous missense variant c.1076C>T, p.(Pro359Leu) in BMP15 was identified.

Conclusions: The biallelic variant c.1076C >T, p.(Pro359Leu) in BMP15 is associated with primary ovarian failure.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rbmo.2022.05.003DOI Listing

Publication Analysis

Top Keywords

primary ovarian
12
homozygous missense
8
ovarian insufficiency
8
ppro359leu bmp15
8
missense variants
4
variants bmpr15
4
bmpr15 result
4
primary
4
result primary
4
insufficiency question
4

Similar Publications

Resistance to platinum-based drugs and PARP inhibitors (PARPi) is the leading cause of treatment failure in epithelial ovarian cancer (EOC). This study aimed to identify resistance mechanisms shared by both. Using bioinformatic analyses, EOC tissues, primary tumor cells and organoids, and chemoresistant cell lines, we identified lymphoid enhancer-binding factor 1 (LEF1) as a candidate, whose expression was increased in both platinum-resistant and PARPi-resistant tumors.

View Article and Find Full Text PDF

[Comparison of live-birth rate after Freeze-All strategy between PCOS and non-PCOS patients].

Gynecol Obstet Fertil Senol

September 2025

Hospices Civils de Lyon, Hôpital Mère Enfant, Service de Médecine de la Reproduction, 59 boulevard Pinel, Bron, France; Université Claude Bernard, Faculté de Médecine Laennec, 7 rue Guillaume Paradin, Lyon, France; INSERM Unité 1208, 18 avenue Doyen Lépine, Bron, France; Université Claude B

Objective: Polycystic Ovarian Syndrome (PCOS) is a common pathology and the most frequent cause of infertility linked to dysovulation. These patients have a high ovarian reserve and, as a result, oocyte collection is often excessive. Following medically assisted reproduction techniques, i.

View Article and Find Full Text PDF

Purpose: Ovarian cancer ranks as a gynecological malignancy with poor prognosis, specifically if detected late. Primary treatment includes cytoreductive surgery and adjuvant chemotherapy with curative intent. Local anesthetics (LA) administered in the perioperative period may potentially impact patient outcome by several mechanisms.

View Article and Find Full Text PDF

Background: Electronic health records (EHRs) are a cornerstone of modern health care delivery, but their current configuration often fragments information across systems, impeding timely and effective clinical decision-making. In gynecological oncology, where care involves complex, multidisciplinary coordination, these limitations can significantly impact the quality and efficiency of patient management. Few studies have examined how EHR systems support clinical decision-making from the perspective of end users.

View Article and Find Full Text PDF

Late peritoneal carcinomatosis from cutaneous melanoma mimicking ovarian cancer.

Melanoma Res

September 2025

Gynecological Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS-CRO, National Cancer Institute Aviano, Aviano.

Peritoneal carcinomatosis represents an exceptionally rare metastatic pattern of cutaneous malignant melanoma, occurring in fewer than 1% of cases with distant spread and typically within the first few years after primary treatment. This report presents an unusual case with a markedly prolonged disease-free interval, clinically mimicking advanced ovarian carcinoma. We report the case of a 53-year-old woman treated more than 10 years ago for stage IIB nodular melanoma with surgery and adjuvant therapy.

View Article and Find Full Text PDF